Intelligent Bio Solutions (NASDAQ:INBS) Stock Price Crosses Above 50-Day Moving Average – What’s Next?

Intelligent Bio Solutions Inc. (NASDAQ:INBS)’s stock price crossed above its 50-day moving average during trading on Friday. The stock has a 50-day moving average of $1.82 and traded as high as $2.00. Intelligent Bio Solutions shares last traded at $1.97, with a volume of 73,603 shares traded.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of Intelligent Bio Solutions in a research report on Thursday, October 15th. One investment analyst has rated the stock with a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Reduce”.

Intelligent Bio Solutions Price Performance

The stock has a 50 day moving average price of $1.82 and a two-hundred day moving average price of $2.98. The firm has a market capitalization of $6.54 million, a price-to-earnings ratio of -0.22 and a beta of 4.48.

About Intelligent Bio Solutions

Intelligent Bio Solutions Inc (NASDAQ: INBS) is a life sciences company focused on developing and commercializing non-invasive diagnostic and screening technologies. Its primary product is the Intelligent Bio Solutions Drug Screening System, a portable platform designed to detect drugs of abuse through sweat collected from a person’s fingerprint.

The system uses a disposable drug screening cartridge and a handheld reader to analyze fingerprint sweat and provide results rapidly. The company markets the technology for applications such as workplace testing, law enforcement, rehabilitation programs, and other settings that require convenient, observed drug screening.

Intelligent Bio Solutions was formerly known as GBS Inc and adopted its current name following its acquisition and integration of Intelligent Fingerprinting, a United Kingdom-based developer of fingerprint-based drug screening technology.